Clene Nanomedicine
Biopharmaceutical company focused on the development of unique therapeutics for neurodegenerative diseases. Learn more
Launch date
Employees
Market cap
€37.3m
Enterprise valuation
€47m (Public information from Sep 2024)
Share price
$5.19 CLNN
Salt Lake City Utah (HQ)
Authorizing premium user...